Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
  1. 4 Grant or award Chief Executive Officer acquired 4,015 shares (grant or award)
  2. 4 Grant or award Chief Executive Officer acquired 4,785 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 3,083 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 3,253 shares (grant or award)
  5. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $4.00 ($20,000)
  6. 4 Grant or award Chief Executive Officer acquired 2,765 shares (grant or award)
  7. 4 Grant or award Chief Executive Officer acquired 2,978 shares (grant or award)
  8. 4 Grant or award Chief Executive Officer acquired 2,908 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 17,400 shares (grant or award)
  10. 4 Grant or award President acquired 93,200 shares (grant or award)
  11. 4 Grant or award Chief Executive Officer acquired 99,300 shares (grant or award)
  12. 4/A Derivatives Options or other derivatives
  13. 4/A Derivatives Options or other derivatives
  14. 4/A Derivatives Options or other derivatives
  15. 4/A Derivatives Options or other derivatives
  16. 4/A Derivatives Options or other derivatives
  17. 4/A Derivatives Options or other derivatives
  18. 4/A Derivatives Options or other derivatives
  19. 4/A Derivatives Options or other derivatives
  20. 4/A Derivatives Options or other derivatives

Page 4 of 14 · 261 filings